Erythropoietin drives breast cancer progression by activation of its receptor EPOR-Reference-Cited by-同舟云学术

Erythropoietin drives breast cancer progression by activation of its receptor EPOR

Published:2017-03-18 Issue:24 Volume:8 Page:38251-38263
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chan Ka Kui¹²,Matchett Kyle B.¹,Coulter Jonathan A.³,Yuen Hiu-Fung¹,McCrudden Cian M.³,Zhang Shu-Dong¹⁴,Irwin Gareth W.¹,Davidson Matthew A.¹,Rülicke Thomas⁵,Schober Sophie⁵,Hengst Ludger⁶,Jaekel Heidelinde⁶,Platt-Higgins Angela⁷,Rudland Philip S.⁷,Mills Ken I.¹,Maxwell Perry⁸,El-Tanani Mohamed¹⁹,Lappin Terence R.¹

Affiliation:

1. Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT9 7AE, UK

2. Department of Pathology, The University of Hong Kong, Hong Kong Special Administrative Region Hong Kong 999077, China

3. School of Pharmacy, Queen's University Belfast, Belfast BT9 7AE, UK

4. Northern Ireland Centre for Stratified Medicine, Biomedical Sciences Research Institute, Ulster University, Londonderry BT47 6SB, UK

5. Institute of Laboratory Animal Science, University of Veterinary Medicine Vienna, Vienna A-1210, Austria

6. Division of Medical Biochemistry, Biocenter, Innsbruck Medical University, Innsbruck A-6020, Austria

7. Institute of Integrative Biology, University of Liverpool, Liverpool L69 3BX, UK

8. Northern Ireland Molecular Pathology Laboratory, Belfast Health & Social Care Trust, Queen's University Belfast, Belfast BT9 7AE, UK

9. Institute of Cancer Therapeutics, University of Bradford, Bradford, West Yorkshire BD7 1DP, UK

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discrete-state models identify pathway specific B cell states across diseases and infections at single-cell resolution;Journal of Theoretical Biology;2024-04

2. Erythropoietin: A Personal Alice in Wonderland Trip in the Shadow of the Giants;Biomolecules;2024-03-27

3. Integrative analysis and risk model construction for super‑enhancer‑related immune genes in clear cell renal cell carcinoma;Oncology Letters;2024-03-01

4. Novel Combination of Erythropoietin and Romiplostim to Treat Chemotherapy-Induced Anemia and Thrombocytopenia via Pharmacodynamic Interaction on Hematopoietic Stem and Progenitor Cells;ACS Pharmacology & Translational Science;2023-11-15

5. Erythropoietin receptor is a risk factor for prognosis: A potential biomarker in lung adenocarcinoma;Pathology - Research and Practice;2023-11